España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Bristol-Myers Squibb
BMY
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
The dividend Ex-Date is tomorrow
Bristol-Myers Squibb (BMY) Forecast
News
Earnings
Bristol-Myers Squibb (BMY) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Bristol-Myers Squibb (NYSE:BMY) Stock
Bristol-Myers Squibb Stock (NYSE: BMY)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, December 31, 2024
Decoding Bristol-Myers Squibb's Options Activity: What's the Big Picture?
Benzinga Insights
Peering Into Bristol-Myers Squibb's Recent Short Interest
Benzinga Insights
Monday, December 30, 2024
Halozyme and Bristol Myers Squibb Secure FDA ...
Benzinga Newsdesk
Reported Friday, Bristol Myers Squibb Receive...
Benzinga Newsdesk
Monday, December 23, 2024
Schwab US Dividend Equity ETF Reverses In December: What's Going On?
Erica Kollmann
Bristol Myers Squibb's Sotyktu Shows Results ...
Benzinga Newsdesk
Bristol Myers Squibb Wins EU Approval for New...
Benzinga Newsdesk
Sunday, December 22, 2024
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Vandana Singh
Thursday, December 19, 2024
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
Vandana Singh
BioArctic Partners With Bristol Myers Squibb ...
Benzinga Newsdesk
Wednesday, December 18, 2024
insitro Receives $25M In Milestone Payments F...
Benzinga Newsdesk
Tuesday, December 17, 2024
Sanofi's 340B Credit Proposal Draws Federal Warning For Statutory Violation
Vandana Singh
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
Avi Kapoor
Monday, December 16, 2024
Bristol-Myers Squibb Shares Rise After Analyst Upgrades, Positive Pipeline Outlook
Vaishali Prayag
9 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Reported Friday, December 13, 2024, Bristol M...
Benzinga Newsdesk
Tesla To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Monday
Avi Kapoor
Jefferies Upgrades Bristol-Myers Squibb to Bu...
Benzinga Newsdesk
Friday, December 13, 2024
Bristol-Myers Squibb Notified Century Therape...
Benzinga Newsdesk
Bristol-Myers Squibb Co Files For Mixed Shelf...
Benzinga Newsdesk
Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report
Vandana Singh
Wednesday, December 11, 2024
Bristol Myers Squibb Increases Quarterly Divi...
Benzinga Newsdesk
Tuesday, December 10, 2024
B of A Securities Reinstates Neutral on Brist...
Benzinga Newsdesk
Monday, December 09, 2024
Bristol Myers Squibb Reports Results From 18 ...
Benzinga Newsdesk
Tuesday, December 03, 2024
AI Proteins Enters A Research Collaboration A...
Benzinga Newsdesk
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 4% Dividend Yields
Avi Kapoor
Monday, December 02, 2024
Why Is Purple Biotech Stock Trading Higher On Monday?
Vandana Singh
Friday, November 29, 2024
Bristol-Myers Squibb Files Lawsuit Against US Agency For Overreach In 340B Drug Pricing Program
Vandana Singh
Monday, November 18, 2024
Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases
Vandana Singh
Friday, November 15, 2024
Shares of pharmaceutical companies are tradin...
Benzinga Newsdesk
Bristol-Myers Faces Renewed $6.7 Billion Lawsuit Over Drug Approval Delays Amid Resolved Trustee Issue
Vandana Singh
Committee For Medicinal Products For Human Us...
Benzinga Newsdesk
Wolfe Research Initiates Coverage On Bristol-...
Benzinga Newsdesk
Wednesday, November 13, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Syros Pharmaceuticals Stock Sinks As Pivotal Blood Cancer Trial Flunks, Triggers Loan Default
Vandana Singh
Tuesday, November 12, 2024
Citigroup Maintains Neutral on Bristol-Myers ...
Benzinga Newsdesk
AbbVie's Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio
Vandana Singh
This Bristol-Myers Squibb Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Avi Kapoor
Bristol-Myers Squibb's $14 Billion Potential - Analyst Upgrades Stock
Vandana Singh
BMO Capital Maintains Market Perform on Brist...
Benzinga Newsdesk
Morgan Stanley Maintains Underweight on Brist...
Benzinga Newsdesk
Leerink Partners Upgrades Bristol-Myers Squib...
Benzinga Newsdesk
Monday, November 11, 2024
What's Going On With Bristol-Myers Squibb Shares Monday?
Dylan Berman
AbbVie's Emraclidine For Schizophrenia 'Surprisingly Disappoints,' Analyst Says Pipeline Is Underappreciated
Vandana Singh
Private Equity Triton Partners Takes Around 10% Stake In Evotec, Reportedly Mulls Potential Takeover Deal
Vandana Singh
AbbVie Stock Slips As $9 Billion Schizophrenia Studies Flunk, Bristol-Myers Stock Surges
Vandana Singh
MARA Holdings, RadNet, Bit Digital, Coinbase And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Bristol-Myers Squibb shares are trading highe...
Benzinga Newsdesk
Bristol Myers Squibb To Showcase Cardiovascul...
Benzinga Newsdesk
Friday, November 08, 2024
Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
Vandana Singh
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch